S. Cattan

Crohn's disease clinical course and severity in obese patients

Antoine Blain, S. Cattan, Laurent Beaugerie et al. · Clinical Nutrition · 2002 · 226 citations

Obesity, Gastroenterology, Obese Patients +2

Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score

Antoine Hollebecque, S. Cattan, Onofrio Romano et al. · Alimentary Pharmacology & Therapeutics · 2011 · 109 citations

Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)

Laëtitia Dahan, Franck Bonnetain, Marc Ychou et al. · Gut · 2010 · 81 citations · Full text

Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM)

Christophe Louvet, Thierry André, Pascal Hammel et al. · Annals of Oncology · 2001 · 45 citations

Surgical Oncology, Oncology, Phase Ii Trial +9

Hepatocellular carcinoma and focal hepatic glycogenosis after prolonged azathioprine therapy

S. Cattan, Dominique Wendum, Olivier Chazouillères et al. · Human Pathology · 2000 · 31 citations

Hepatology, Medicine, Liver Physiology +13